Tuesday, July 16, 2019
Antibody nanoparticles override immunological tolerance of tumors
Scientists have developed a tumor enzymatic microenvironment-activatable antibody nanoparticle for robust cancer immunotherapy.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Scientists have developed a tumor enzymatic microenvironment-activatable antibody nanoparticle for robust cancer immunotherapy.
No comments:
Post a Comment